Danaher Corp (NY:DHR)

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...

Topics Economy

1 S&P 500 Stock Worth Your Attention and 2 Facing Headwinds

March 13, 2026

As of March 10, 2026, the United States financial markets are witnessing an unprecedented explosion in Mergers and Acquisitions (M&A) that has caught even the most optimistic analysts by surprise....

Topics Stocks

The $2.5 Trillion Tsunami: Why 2026 has Become the Year of the Megadeal

March 10, 2026

As the first quarter of 2026 draws to a close, the healthcare and life sciences sectors are grappling with a "new normal" defined by capital conservatism and geopolitical friction. Industry...

Topics Artificial Intelligence Economy Government

Danaher Corp (NYSE:DHR) Q4 2025 Earnings: Revenue Miss Offsets EPS Beat, Shares Dip ↗

January 28, 2026

Via Chartmill

Danaher Corp (NYSE:DHR) Shows Strong Technical Setup for Potential Breakout ↗

January 28, 2026

Via Chartmill

Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks

March 09, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Topics Artificial Intelligence Economy Intellectual Property

1 Profitable Stock to Target This Week and 2 We Avoid

March 02, 2026

The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026

February 27, 2026

WALTHAM, MA — In a market defined by shifting geopolitical alliances and a renewed "flight to quality," Thermo Fisher Scientific (NYSE:TMO) has once again asserted its dominance as the bedrock of the...

As AI uncertainty weighs on stocks, consider loading up on these dividend-growth blue chips instead.

Topics Earnings Economy World Trade

The Smartest Dividend Stocks to Buy With $2,000 Right Now ↗

February 21, 2026

Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape

Topics Artificial Intelligence

February 19, 2026

On January 15, 2026, the medical technology sector witnessed its most significant seismic shift in years as Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire...

Danaher’s $9.9 Billion Acquisition of Masimo: A Strategic Pivot to the Future of Patient Monitoring

February 19, 2026

In a move that has sent shockwaves through the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to acquire...

Masimo supplies noninvasive monitoring tech to hospitals and care providers, serving both medical and consumer health markets worldwide.

Topics Artificial Intelligence Economy

Naya Capital Adds Masimo Shares ↗

February 19, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Topics Regulatory Compliance

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky

February 18, 2026

Billionaire Investors Warren Buffett, Bill Ackman and Other Have Been Buying These Stocks ↗

February 18, 2026

Every quarter, we get to see what the best of the best have bought and sold.

In a move that signals a massive consolidation in the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to...

Danaher's $9.9 Billion Bet: Masimo Acquisition to Redefine the Diagnostics Landscape

February 17, 2026

As of February 17, 2026, Danaher Corporation (NYSE: DHR) finds itself at a pivotal juncture in its multi-decade evolution. Once the darling of the "compounding" investment community, the Washington,...

Topics Artificial Intelligence Economy

Danaher Corporation (DHR): Navigating the Bioprocessing Thaw and the Masimo Pivot

February 17, 2026

Via Finterra

Topics Artificial Intelligence Earnings Supply Chain

Discover the top S&P500 movers in Tuesday's pre-market session. ↗

February 17, 2026

Via Chartmill

Danaher Deal Finalized: Company To Acquire Masimo For $9.9 Billion In Cash ↗

February 17, 2026

The deal will entail Danaher paying $180 per share for Masimo, reflecting about 18 times Masimo’s projected 2027 earnings before interest, taxes, depreciation, and amortization.

Via Stocktwits

Masimo Heads For $10B Buyout After Winning Blood Oxygen Patent Case Against Apple ↗

February 17, 2026

Danaher is reportedly set to acquire Masimo, with the deal expected to be announced as early as Tuesday.

Via Stocktwits

Topics Intellectual Property

Water Powerhouse at a Crossroads: A Deep Dive into Xylem Inc (XYL) in 2026

February 11, 2026

On February 11, 2026, the global water technology leader Xylem Inc (NYSE: XYL) finds itself at a critical crossroads. Following the release of its full-year 2025 earnings report just yesterday, the...

Via Finterra

Topics Artificial Intelligence Intellectual Property

The Measurement Giant Reimagined: A Deep Dive into Waters Corporation (WAT) in 2026

February 10, 2026

As of February 10, 2026, Waters Corporation (NYSE: WAT) stands at the most significant crossroads in its nearly 70-year history. Long regarded as the gold standard in liquid chromatography and mass...

Via Finterra

Topics Economy

The Evolution of a Compounder: A Deep-Dive Into Fortive Corp (FTV)

February 05, 2026

As of February 5, 2026, Fortive Corp (NYSE: FTV) finds itself at a pivotal crossroads. Long known as the "industrial-tech compounder" born from the Danaher heritage, the company has recently completed...

Via Finterra

Topics Artificial Intelligence Earnings Electric Vehicles

Cold Chain, High Stakes: A Deep Dive into Azenta’s (AZTA) Life Sciences Transformation

February 05, 2026

Date: February 5, 2026 Introduction In the high-stakes world of life sciences, the "cold chain" is the invisible backbone of modern medicine. From the development of mRNA vaccines to the emerging...

Via Finterra

Topics Artificial Intelligence Earnings Economy

The Top 5 Analyst Questions From Danaher’s Q4 Earnings Call

February 04, 2026

Danaher’s fourth quarter results met Wall Street’s revenue expectations, with management attributing performance to ongoing strength in its bioprocessing segment and steady growth in diagnostics. CEO...

DHR Q4 Deep Dive: Bioprocessing and Diagnostics Drive Steady Performance Amid Muted End Markets

Topics Earnings

January 29, 2026

Diversified science and technology company Danaher (NYSE:DHR) met Wall Streets revenue expectations in Q4 CY2025, with sales up 4.6% year on year to $6.84 billion. Its non-GAAP profit of $2.23 per...

In the high-stakes world of the S&P 500, few companies have mastered the art of the "quiet compounder" as effectively as Roper Technologies, Inc. (NYSE: ROP). Long known as the textbook example of a...

What's going on in today's session: S&P500 movers ↗

January 28, 2026

Via Chartmill

The Quiet Compounder’s Reckoning: A Deep Dive into Roper Technologies (ROP)

January 28, 2026

Via Finterra

Topics Artificial Intelligence Earnings Economy

Danaher (DHR) Q4 2025 Earnings Call Transcript ↗

January 28, 2026

Danaher (DHR) Q4 2025 Earnings Call Transcript

Diversified science and technology company Danaher (NYSE:DHR) met Wall Streets revenue expectations in Q4 CY2025, with sales up 4.6% year on year to $6.84 billion. Its non-GAAP profit of $2.23 per...

Topics Earnings

Danaher (NYSE:DHR) Posts Q4 CY2025 Sales In Line With Estimates

January 28, 2026

The Small-Cap M&A Boom of 2026: How $440 Billion in Dry Powder and Rate Cuts Are Remaking the Market

January 27, 2026

As of January 27, 2026, the financial landscape has undergone a dramatic transformation. After a prolonged "deal winter" that chilled the markets through 2023 and much of 2024, the small-cap sector is...